Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 8.22% |
AMGEN INC. | AMGN | 6.26% |
GILEAD SCIENCES, INC. | GILD | 4.65% |
REGENERON PHARMACEUTICALS | REGN | 4.01% |
VERTEX PHARMACEUTICALS | VRTX | 3.98% |
ALNYLAM PHARMACEUTICALS | ALNY | 2.92% |
CORTEVA INC | CTVA | 2.81% |
MODERNA INC | MRNA | 2.55% |
BIOGEN IDEC, INC. | BIIB | 2.47% |
ASTRAZENECA PLC ADR | AZN | 2.45% |
ILLUMINA INC | ILMN | 1.95% |
UNITED THERAPEUTICS CORP | UTHR | 1.81% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.78% |
VIATRIS INC | VTRS | 1.74% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.73% |
SAREPTA THERAPEU | SRPT | 1.71% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.71% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.69% |
INCYTE CORP | INCY | 1.66% |
INSMED INC | INSM | 1.65% |
ARGENX SE - ADR | ARGX | 1.46% |
NATERA INC | NTRA | 1.45% |
EXACT SCIENCES | EXAS | 1.41% |
ALKERMES PLC | ALKS | 1.39% |
INTRA-CELLULAR T | ITCI | 1.35% |
IONIS PHARMACEUTICALS, IN | IONS | 1.28% |
VIKING THERAPEUTICS INC | VKTX | 1.26% |
HALOZYME THERAPEUTICS INC | HALO | 1.25% |
REVOLUTION MEDICINES INC | RVMD | 1.25% |
VAXCYTE INC | PCVX | 1.18% |
CYTOKINETICS INC | CYTK | 1.18% |
EXELIXIS, INC. | EXEL | 1.15% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.11% |
MEDPACE HOLDINGS | MEDP | 1.10% |
CRISPR THERAPEUTICS AG | CRSP | 1.04% |
ROIVANT SCIENCES LTD | ROIV | 1.00% |
CRINETICS PHARMACEUTICALS | CRNX | 0.93% |
BLUEPRINT MEDICI | BPMC | 0.91% |
AXSOME THERAPEUT | AXSM | 0.89% |
BIONTECH SE-ADR | BNTX | 0.88% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.87% |
GUARDANT HEALTH INC | GH | 0.86% |
ULTRAGENYX PHARM | RARE | 0.84% |
CEREVEL THERAPEUTICS HOLD | CERE | 0.83% |
PROTHENA CORP PL | PRTA | 0.83% |
BRIDGEBIO PHARMA INC | BBIO | 0.81% |
TG THERAPEUTICS | TGTX | 0.80% |
APELLIS PHARMACE | APLS | 0.80% |
TWIST BIOSCIENCE CORP | TWST | 0.77% |
BEAM THERAPEUTICS INC | BEAM | 0.75% |
AMICUS THERAPEUTICS INC | FOLD | 0.74% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.73% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.73% |
KRYSTAL BIOTECH INC | KRYS | 0.72% |
NOVAVAX INC | NVAX | 0.70% |
INTELLIA THERAPE | NTLA | 0.68% |
AKERO THERAPEUTICS INC | AKRO | 0.62% |
PTC THERAPEUTICS | PTCT | 0.61% |
IMMUNOVANT INC | IMVT | 0.60% |
MADRIGAL PHARMAC | MDGL | 0.57% |
NUVALENT INC-A | NUVL | 0.56% |
DYNAVAX TECHNOLOGY | DVAX | 0.53% |
SPRINGWORKS THERAPEUTICS | SWTX | 0.52% |
RECURSION PHARMACEUTICALS | RXRX | 0.52% |
ARDELYX INC | ARDX | 0.45% |
IRONWOOD PHARMAC | IRWD | 0.45% |
SAGE THERAPEUTIC | SAGE | 0.29% |
PACIFIC BIOSCIEN | PACB | 0.17% |
GRAIL INC | GRAL | 0.04% |
Other (Cash, derivatives and other liabilities) | 0.39% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.